ID   PSM-P12
AC   CVCL_DN67
DR   Wikidata; Q54948571
RX   Patent=US20030013191;
RX   PubMed=11170126;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2280.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q04609; Human FOLH1/PSMA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 7
//
RX   Patent=US20030013191;
RA   Cussenot, Olivier
RA   Villette, Jean-Marie
RT   "Prostatic cell line and use thereof to obtain an established
RT   prostatic cancer in an animal.";
RL   Patent number US20030013191, 16-Jan-2003.
//
RX   PubMed=11170126; DOI=10.1002/1097-0045(200101)46:1<2::AID-PROS1002>3.0.CO;2-5;
RA   Anidjar, Maurice
RA   Villette, Jean-Marie
RA   Devauchelle, Patrick
RA   Delisle, Francoise
RA   Cotard, Jean-Pierre
RA   Billotey, Claire
RA   Cochand-Priollet, Beatrix
RA   Copin, Henri
RA   Barnoux, Muriel
RA   Triballeau, Sylvie
RA   Rain, Jean-Didier
RA   Fiet, Jean
RA   Teillac, Pierre
RA   Berthon, Philippe
RA   Cussenot, Olivier
RT   "In vivo model mimicking natural history of dog prostate cancer using
RT   DPC-1, a new canine prostate carcinoma cell line.";
RL   Prostate 46:2-10(2001).
//